Penalties for counterfeiting medicines are inadequate,
says Jean-François Dehecq, EFPIA’s anti-counterfeits champion
Paris, 19 June 2008 – Leaders of the research-based pharmaceutical industry meeting in Paris today have called for strong EU measures to tackle the growing threat of counterfeit medicines, including a ban on medicine repackaging, a harmonised EU- system of identification of medicines, and heavier penalties for trafficking in counterfeit medicines.